Atrial Fibrillation Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who are at least 18 years old
• People who have given written consent to participate before any trial-related procedures take place
• People who have been diagnosed with symptomatic paroxysmal atrial fibrillation (a type of irregular heartbeat that starts and stops on its own), confirmed by a doctor's note and a recording from a heart monitor (such as an ECG showing at least 30 seconds of the irregular rhythm)
• People who are already planning to have a heart mapping and ablation procedure to treat their paroxysmal atrial fibrillation
• People who are able and willing to attend all required appointments and testing before, during, and after the procedure

Who may not be able to join:

• People whose main diagnosis is persistent or long-standing atrial fibrillation (continuous irregular heartbeat lasting more than one year)
• People known to have a blood clot inside the heart
• People with a known fluid build-up around the heart of more than 2 mm before the procedure begins
• People with a condition that prevents safe access to their blood vessels for the procedure
• People who have had a device implanted inside the heart within the 30 days before the procedure
• People who are pregnant or breastfeeding
• People who have had open heart surgery involving a cut to the heart wall within the 28 days before the procedure
• People who have had a heart attack, acute coronary syndrome, a coronary artery procedure (such as stenting), or heart bypass or valve surgery within the 90 days before the procedure
• People who have had a stroke or mini-stroke (TIA) within the 90 days before the procedure
• People with a history of blood clotting or bleeding disorders, including abnormally high or low platelet counts, bleeding conditions, or suspected issues with blood-thinning medication
• People who cannot receive heparin (a blood-thinning medication) or a suitable alternative during the procedure
• People with a known allergy or sensitivity to contrast dye (sometimes used during the procedure) that cannot be managed with pre-medication
• People who have previously had surgery on the left side of the heart, including placement of a left atrial appendage closure device
• People with severe leaking of the mitral heart valve (confirm with trial site for specific measurements)
• People who have previously had a tricuspid or mitral heart valve replaced or repaired
• People who have an artificial (prosthetic) heart valve
• People who have a type of non-cancerous heart tumour called a myxoma
• People who have a patch or baffle between the upper chambers of the heart from a previous procedure
• People who have a narrowing, blockage, or stent in a pulmonary vein (the blood vessels connecting the lungs to the heart)
• People with rheumatic heart disease
• People with a condition called hypertrophic cardiomyopathy (a thickening of the heart muscle)
• People with an active infection anywhere in the body
• People with severe lung disease or any serious ongoing lung or breathing condition
• People currently participating in, or who have participated in, another clinical trial within the 30 days before screening, unless the trial sponsor has given prior approval
• People with other health, social, or psychological conditions that, in the opinion of the investigator, could affect their ability to safely participate or complete the trial
• People who do not have legal authority to consent for themselves
• People who are unable to read or write

Important: Always verify eligibility with the trial site directly before applying.